SNSS Financial Facts
Other income (expense), net: -2.96MResearch and development: 7.38M
See Full Income Statement
Accumulated deficit: -456.72M
Total current liabilities: 35.9M
See Full Balance Sheet
Earnings History for Sunesis Pharmaceuticals Inc. (SNSS)
|
Expand Research on SNSS
| Next EPS Date | 8/8/13 *Est. | EPS Growth Rate | +23.3% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -1.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +3.3% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/9/13  |
 |
Q113 | -$0.23 | -$0.20 | -$0.03 | $1.99M | $750K | N/A / N/A | N/A | 0% | Details |
| 3/13/13 |
Q412 | -$0.20 | -$0.19 | -$0.01 | $1.99M | $320K | N/A / N/A | N/A | +1.9% | Details | |
| 11/8/12 |
|
Q312 | -$0.37 | -$0.13 | -$0.24 | $265K | $4.17M | N/A / N/A | N/A | +47.6% | Details |
| 8/9/12 |
|
Q212 | $0.20 | -$0.20 | +$0.40 | $1.5M | N/A | N/A / N/A | N/A | +82.4% | Details |
| 5/15/12 |
|
Q112 | -$0.30 | -$0.18 | -$0.12 | N/A | $90K | N/A / N/A | N/A | +105.6% | Details |
| 3/14/12 |
Q411 | -$0.19 | -$0.19 | $0.00 | N/A | $210K | N/A / N/A | N/A | 0% | Details | |
| 8/11/11 | Q211 | -$0.18 | -$0.15 | -$0.03 | N/A | $10K | N/A / N/A | N/A | 0% | Details | |
| 5/12/11 | Q111 | $0.04 | -$0.14 | +$0.18 | $4M | $13K | N/A / N/A | N/A | +117.9% | Details |
